Cargando…

5610845 A PHASE 1 STUDY OF CSL888 (HEMOPEXIN) IN ADULT PATIENTS WITH SICKLE CELL DISEASE

Detalles Bibliográficos
Autores principales:	Biemond, B.J., Shore, B.J., Wilson, F., Jochems, J., Lindqvist, L.M., Jung, K., Gentinetta, T., Costin, S., Kato, G.J., Eleftheriou, P., Fok, H., Wahab, E., Leung, P.M., Sharif, J., Boucher, A., Fitzgerald, R., Keese-Adu, R., Azbell, R., Liles, D., Bergmann, S., Lanzkron, S., Gordeuk, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112651/ http://dx.doi.org/10.1097/01.HS9.0000928236.70320.48

Ejemplares similares

Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation
por: Poillerat, Victoria, et al.
Publicado: (2020)

Hemopexin and Cancer
por: Fiorito, Veronica, et al.
Publicado: (2022)

Current Evidence and Rationale to Guide Perioperative Management, Including Transfusion Decisions, in Patients With Sickle Cell Disease
por: Azbell, Roberta C. G., et al.
Publicado: (2023)

Immune thrombocytopenia due to COVID‐19 during pregnancy
por: Tang, M.W., et al.
Publicado: (2020)

Clinical Pharmacokinetics and Pharmacodynamics of CSL112
por: Ortega-Paz, Luis, et al.
Publicado: (2023)

Human Plasma and Recombinant Hemopexins: Heme Binding Revisited
por: Karnaukhova, Elena, et al.
Publicado: (2021)

Association between haptoglobin, hemopexin and mortality in adults with sepsis
por: Janz, David R, et al.
Publicado: (2013)

Hemopexin in severe inflammation and infection: mouse models and human diseases
por: Lin, Tian, et al.
Publicado: (2015)

Fungal CSL transcription factors
por: Převorovský, Martin, et al.
Publicado: (2007)

New Insights into Hemopexin-Binding to Hemin and Hemoglobin
por: Lechuga, Guilherme C., et al.
Publicado: (2022)

Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders
por: Smith, Ann, et al.
Publicado: (2015)

Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
por: Lemasson, Benjamin, et al.
Publicado: (2016)

Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence
por: Gentinetta, Thomas, et al.
Publicado: (2022)

Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease
por: Ashouri, Rani, et al.
Publicado: (2021)

Analysis of hemopexin plasma levels in patients with age-related macular degeneration
por: Lauwen, Susette, et al.
Publicado: (2022)

A Role for Hemopexin in Oligodendrocyte Differentiation and Myelin Formation
por: Morello, Noemi, et al.
Publicado: (2011)

Data demonstrating the anti-oxidant role of hemopexin in the heart
por: Ingoglia, Giada, et al.
Publicado: (2017)

Alterations in Systemic Extracellular Heme and Hemopexin Are Associated With Adverse Clinical Outcomes in Ugandan Children With Severe Malaria
por: Elphinstone, Robyn E., et al.
Publicado: (2016)

Comparing Bleeding and Thrombotic Rates in Spine Surgery: An Analysis of 119 888 Patients
por: Pirkle, Sean, et al.
Publicado: (2019)

Evaluation of ABT-888 in the amelioration of α-synuclein fibril-induced neurodegeneration
por: Hastings, Lyndsay, et al.
Publicado: (2022)

miR-888: Hit it when you see it!
por: Bader, Andreas G
Publicado: (2014)

ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
por: Yuan, Alice L., et al.
Publicado: (2018)

OptIC-Notch reveals mechanism that regulates receptor interactions with CSL
por: Townson, Jonathan M., et al.
Publicado: (2023)

ALICE HMPID Csl photocathode coating station
Publicado: (2003)

Dissipative Continuous Spontaneous Localization (CSL) model
por: Smirne, Andrea, et al.
Publicado: (2015)

Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia
por: Dong, Beibei, et al.
Publicado: (2013)

Hemopexin Modulates Expression of Complement Regulatory Proteins in Rat Glomeruli
por: Detsika, Maria G., et al.
Publicado: (2021)

Involvement of Hemopexin in the Pathogenesis of Proteinuria in Children with Idiopathic Nephrotic Syndrome
por: Pukajło-Marczyk, Agnieszka, et al.
Publicado: (2021)

Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
por: Liu, Jing, et al.
Publicado: (2022)

Haptoglobin, hemopexin, and related defense pathways—basic science, clinical perspectives, and drug development
por: Schaer, Dominik J., et al.
Publicado: (2014)

888. Improving outcomes with revised preoperative universal decolonization protocol
por: Gnass, Silvia I
Publicado: (2020)

888. A Predictive Model for Subtherapeutic Vancomycin Troughs in Adults
por: Crisp, Sarah, et al.
Publicado: (2022)

XL888 limits vemurafenib-induced proliferative skin events by suppressing paradoxical MAPK activation
por: Phadke, Manali, et al.
Publicado: (2015)

Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity
por: Kingwell, Bronwyn A., et al.
Publicado: (2022)

(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic
por: Ehab, J., et al.
Publicado: (2023)

Plasma Heme Scavengers Alpha-1-Microglobulin and Hemopexin as Biomarkers in High-Risk Pregnancies
por: Kalapotharakos, Grigorios, et al.
Publicado: (2019)

Fission Yeast CSL Proteins Function as Transcription Factors
por: Oravcová, Martina, et al.
Publicado: (2013)

Dishevelled limits Notch signalling through inhibition of CSL
por: Collu, Giovanna M., et al.
Publicado: (2012)

Hemopexin as biomarkers for analyzing the biological responses associated with exposure to silica nanoparticles
por: Higashisaka, Kazuma, et al.
Publicado: (2012)

Lack of Plasma Protein Hemopexin Results in Increased Duodenal Iron Uptake
por: Fiorito, Veronica, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_08fa2mo9r0io1br5m88p6pirf4